Wells Fargo’s AEON Biopharma AEON Stock Holding History

Wells Fargo’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$89	Hold	90	–	–	﹤0.01%	6516
2025 Q4	$99	Hold	90	–	–	﹤0.01%	6431
2025 Q3	$73	Hold	90	–	–	﹤0.01%	6425
2025 Q2	$68	Hold	90	–	–	﹤0.01%	6532
2025 Q1	$52	Hold	90	–	–	﹤0.01%	6449
2024 Q4	$3.51K	Buy	+90	New	+$5.24K	﹤0.01%	6118
2024 Q2	–	Sell	-2	Closed	-$1.61K	–	6874
2024 Q1	$1.61K	Hold	2	–	–	﹤0.01%	6067
2023 Q4	$986	Hold	2	–	–	﹤0.01%	6226
2023 Q3	$728	Buy	+2	New	+$916	﹤0.01%	6274
2022 Q1	–	Sell	-3,945	Closed	-$2.76M	–	6976
2021 Q4	$2.76M	Hold	3,945	–	–	﹤0.01%	3176
2021 Q3	$2.77M	Hold	3,945	–	–	﹤0.01%	3392
2021 Q2	$2.73M	Buy	+3,945	New	+$2.76M	﹤0.01%	3409

Other funds holding AEON

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo's AEON Position: Q1 2026 in Review

Wells Fargo held its AEON Biopharma (AEON) position steady in Q1 2026 at 90 shares worth $89. The position accounts for ﹤0.01% of the portfolio, ranked #6516.

Wells Fargo first reported a position in AEON in Q2 2021 and has held it in 12 quarters since. The position peaked at $2.77M in Q3 2021. 24 funds tracked by Wall St. Rank hold AEON as of Q1 2026.

Wells Fargo held 90 shares of AEON Biopharma worth $89 as of Q1 2026.
Wells Fargo left its AEON Biopharma share count unchanged in Q1 2026.
AEON Biopharma made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6516 holding.
Wells Fargo first reported a position in AEON Biopharma in Q2 2021 and has held it in 12 quarters since.
Wells Fargo's AEON Biopharma position peaked at $2.77M in Q3 2021.
24 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.